WT1 and neoplasm: However, ER-positive and ER-negative breast cancers have been thought to represent distinct disease entities,37,53 and ER-negative breast cancers have poorer clinical outcomes than ER-positive tumours.34 In this study, ER-positive tumours show greater vascularisation and WT1 endothelial expression compared with ER-negative cancers.